BB Biotech AG's Form 4 filing
Black Diamond Therapeutics, Inc. (BDTX) · filed Jun 29, 2023
- Accession no.
- 0000899243-23-016705
- Filed
- Jun 29, 2023, 1:37 PM ET
- Trade date
- Jun 27, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $9.56M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BB Biotech AGCIK 0000924223 | 10% Owner |
| Biotech Growth N VCIK 0001259869 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2023 | Common Stock | PPurchaseAcquired | +1,740,000 | $5.49 | +$9,555,036 | 7,117,839 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.